Disrupted lung development and bronchopulmonary dysplasia: Opportunities for lung repair and regeneration

Current Opinion in Pediatrics

Volumn 26, Issue 3, 2014, Pages 306-314

  Baker, Christopher D ^a   Alvira, Cristina M ^b  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alveolarization; chronic lung disease; lung regeneration; prematurity; stem cells

Indexed keywords

OXYGEN;

ASSISTED VENTILATION; CELL TRANSPLANTATION; CLINICAL EFFECTIVENESS; COLONY FORMING CELL; EARLY CHILDHOOD INTERVENTION; ENDOTHELIAL PROGENITOR CELL; HUMAN; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG ENDOTHELIUM; LUNG FUNCTION; LUNG INJURY; LUNG REGENERATION; MESENCHYMAL STROMA CELL; META ANALYSIS (TOPIC); NONHUMAN; ORGAN GROWTH; OXYGEN THERAPY; PEDIATRICS; POSITIVE END EXPIRATORY PRESSURE; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; BRONCHOPULMONARY DYSPLASIA; GROWTH, DEVELOPMENT AND AGING; LUNG; MOLECULARLY TARGETED THERAPY; NEWBORN; ORGANOGENESIS; PATHOPHYSIOLOGY; PROCEDURES; REGENERATION; SURVIVAL; TRENDS;

BRONCHOPULMONARY DYSPLASIA; HUMANS; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; LUNG; MOLECULAR TARGETED THERAPY; ORGANOGENESIS; REGENERATION; SURVIVAL ANALYSIS;

EID: 84900418424     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000095     Document Type: Review

References (89)

1. Galambos C Demello DE. Regulation of alveologenesis: clinical implications of impaired growth. Pathology 2008 40 124-140
2. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163:1723-1729
3. Doyle LW, Faber B, Callanan C, et al. Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence. Pediatrics 2006; 118:108-113
4. Fakhoury KF, Sellers C, Smith EO, et al. Serial measurements of lung function in a cohort of young children with bronchopulmonary dysplasia. Pediatrics 2010; 125:e1441-e1447
5. Balinotti JE, Chakr VC, Tiller C, et al. Growth of lung parenchyma in infants and toddlers with chronic lung disease of infancy. Am J Respir Crit Care Med 2010; 181:1093-1097
6. Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia. Lancet 2006; 367:1421-1431
7. Northway WH Jr., Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967; 276:357-368
8. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 1999; 46:641-643
9. Hisl op AA. Airway and blood vessel interaction during lung development. J Anat 2002; 201:325-334
10. Metzger RJ, Klein OD, Martin GR, Krasnow MA. The branching programme of mouse lung development. Nature 2008; 453:745-750
11. Copland I, Post M. Lung development and fetal lung growth. Paediatr Respir Rev 2004; 5 (Suppl A):S259-S264
12. Roth-Kleiner M, Post M. Similarities and dissimilarities of branching and septation during lung development. Pediatr Pulmonol 2005; 40:113-134
13. Burri PH. Structural aspects of postnatal lung development-alveolar formation and growth. Biol Neonate 2006; 89:313-322
14. Flamme I, Risau W. Induction of vasculogenesis and hematopoiesis in vitro. Development 1992; 116:435-439
15. Risau W. Mechanisms of angiogenesis. Nature 1997; 386:671-674
16. Groenman F, Unger S, Post M. The molecular basis for abnormal human lung development. Biol Neonate 2005; 87:164-177
17. Bourbon J, Boucherat O, Chailley-Heu B, Delacourt C. Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia. Pediatr Res 2005; 57:3 8R-46R
18. Chambers HM, van Velzen D. Ventilator-related pathology in the extremely immature lung. Pathology 1989; 21:79-83
19. Hislop AA, Haworth SG. Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease. Pediatr Pulmonol 1990; 9:152-161
20. Coalson JJ. Pathol ogy of new bronchopulmonary dysplasia. Semin Neonatol 2003; 8:73-81
21. LeBlanc MH,Graves GR, Rawson TW, Moffitt J. Long-term outcome of infants at the margin of viability. J Miss State Med Assoc 1999; 40:111-114
22. Allen J, Zwerdling R, Ehrenkranz R, et al. Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med 2003; 168:356-396
23. Baraldi E Filippone M. Chronic lung disease after premature birth. N Engl J Med 2007 357 1946-1955
24. Coalson JJ. Pathology of chronic lung diseas e of early infancy. In Bland RD, Coalson JJ, editors. Chronic lung disease in early infancy. New York: Marcel Dekker; 1999. pp. 85-124. (Lenfant C (series editor): Lung biology in health and disease, vol. 137)
25. Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998; 29:710-717
26. Abman SH. Bronchopulmonary dysplasi a: 'a vascular hypothesis'. Am J Respir Crit Care Med 2001; 164:1755-1756
27. Bhatt AJ, Pryhuber GS, Huyck H, et al. Disrupted pulmonary vasculature and decreased vascular endothelial growt h factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 164:1971-1980
28. Iosef C, Alastalo TP, Hou Y, et al. Inhibiting NF-kappaB in t he developing lung disrupts angiogenesis and alveolarization. Am J Physiol Lung Cell Mol Physiol 2012; 302:L1023-L1036
29. Thébaud B, Ladha F, Michelakis ED, et al. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 2005; 112:2477-2486
30. Jakkula M, Le Cras TD, Gebb S, et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 2000; 279:L600-L607
31. Mourani PM, Abman SH. Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond. Curr Opin Pediatr 2013; 25:329-337
32. Bancalari E, Abdenour GE, Feller R, Gannon J. Bronchopulmonary dysplasia: clinical presentation. J Pediatr 1979; 95:819-823
33. Walsh MC, Wilson-Costello D, Zadell A, et al. Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia. J Perinatol 2003; 23:451-456
34. Collins CL, Holberton JR, Konig K. Comparison of the ph aryngeal pressure provided by two heated, humidified high-flow nasal cannulae devices in premature infants. J Paediatr Child Health 2013; 49:554-556
35. Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010; 126:443-456
36. Stroustrup A, Trasande L. Epidemiological characteristics and resource use in neonates with bronchopulmonary dysplasia: 1993-2006. Pediatrics 2010; 126:291-297
37. Latini G, De Felice C, Giannuzzi R, Del Vecchio A. Survival rate and prevalence of bronchopulmonary dysplasia in extremely low birth weight infants. Early Hum Dev 2013; 89 (Suppl 1):S69-S73
38. Ali Z, Schmidt P, Dodd J, Jeppesen DL. Bronchopulmonary dysplasia: a review. Arch Gynecol Obstet 2013; 288:325-333
39. Bhandari V, Bizzarro MJ, Shetty A, et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 2006; 117:1901-1906
40. Lavoie PM, Pham C, Jang KL. Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health. Pediatrics 2008; 122:479-485
41. Wang H, St Julien KR, Stevenson DK, et al. A genome-wide association study (GWAS) for bronchopulmonary dysplasia. Pediatrics 2013; 132:290-297
42. Eriksson L, Haglund B, Odli nd V, et al. Prenatal inflammatory risk factors for development of bronchopulmonary dysplasia. Pediatr Pulmonol 2013. [Epub ahead of print]
43. Durrmeyer X, Kayem G, Sinico M, et al. Perinatal risk factors for bronchopulmonary dysplasia in extremely low gestational age infants: a pregnancy disorder-based approach. J Pediatr 2012; 160:578-583
44. Hansen AR Barnés CM, Folkman J, McElrath TF. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. J Pediatr 2010 156 532-536
45. Been JV, Zimmermann LJ. Histological chorioamnionitis and respiratory outcomein preterminfants. Arch Dis Child FetalNeonatalEd2009;94:F218-225
46. Lee HJ, Kim E-K, Kim H-S, et al. Chorioamnionitis, respiratory distress syndrome and bronchopulmonary dysplasia in extremely low birth weight infants. J Perinatol 2011; 31:166-170
47. Fanaroff AA, Korones SB, Wright LL, et al. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Developmen t Neonatal Research Network. Pediatr Infect Dis J 1998; 17:593-598
48. Klinger G, Levy I, Sirota L, et al. Outcome of early-onset sepsis in a national cohort of very low birth weight infants. Pediatrics 2010; 125:e736-e740
49. Shima Y, Kumasaka S, Migita M. Perinatal risk factors for adverse long-term pulmonary outcome in premature infants: comparison of different definitions of bronchopulmona ry dysplasia/chronic lung disease. Pediatr Int 2013; 55: 578-581
50. Laughon M, Allred EN, Bose C, et al. Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants. Pediatrics 2009; 123:1124-1131
51. Fischer HS, Buhrer C. Avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: a meta-analysis. Pediatrics 2013; 132:e1351-e1360
52. Bancalari E, Claure N, Sosenko IR. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol 2003; 8:63-71
53. Kaempf JW, Wu YX, Kaempf AJ, et al. What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants J Perinatol 2012; 32:344-348
54. Chock VY, Punn R, Oza A, et al. Predictors of bronchopulmonary dysplasia or death in premature infants with a patent ductus arteriosus. Pediatr Res 2014; 75:570-575
55. Li Y, Yan J, Li M, et al. Addition of SNAP to p erinatal risk factors improves the prediction of bronchopulmonary dysplasia or death in critically ill preterm infants. BMC Pediatr 2013; 13:138. A physiologic severity index on the first day of life was associated with an increased risk of BPD or death in critically ill preterm infants
56. Schmölzer GM, Kumar M, Pichler G, et al. Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and metaanalysis. BMJ 2013; 347:f5980
57. Askie LM. Optimal oxygen saturations in preterm infants: a moving target. Curr Opin Pediatr 2013; 25:188-192
58. Carlo WA, Finer NN, Walsh MC, et al. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 2010; 362:1959-1969
59. Schmidt B, Whyte RK, Asztalos EV, et al. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. JAMA 2013; 309:2111-2120
60. Stenson BJ, Tarnow-Mordi WO, Darlow BA, et al. Oxygen saturation and outcomes in preterm infants. N Engl J Med 2013; 368:2094-2104
61. Vento M, Moro M, Escrig R, et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics 2009; 124:e439-e449
62. Manley BJ, Owen LS, Doyle LW, et al. High-flow nasal cannulae in very preterm infants after extubation. N Engl J Med 2013; 369:1425-1433. In very preterm infants, high-f low oxygen and nasal CPAP had similar failure rates after extubation
63. Yoder BA, Stoddard RA, Li M, et al. Heated, humidified high-flow nasal cannula versus nasal CPAP for respiratory support in neonates. Pediatrics 2013; 131:e1482-e1490
64. Fawke J, Lum S, Kirkby J, et al. Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study. Am J Respir Crit Car e Med 2010; 182:237-245
65. Lum S Kirkby J Welsh L et al. Nature and severity of lung function abnormalities in extremely preterm children at 11 years of age.i Eur Respir J 2011 37 1199-1207
66. Smith LJ, van Asperen PP, McKay KO, et al. Reduced exercise capacity in children born very preterm. Pediatrics 2008; 122:e287-e293
67. Cazzato S, R idolfi L, Bernardi F, et al. Lung function outcome at school age in very low birth weight children. Pediatr Pulmonol 2013; 48:830-837
68. Thane K, Ingenito EP, Hoffman AM. Lung regeneration and translational implications of the postpneumonectomy model. Transl Res 2014; 163: 363-376
69. Voswinckel R, Motejl V, Fehrenbach A, et al. Characterisation of postpneumonectomy lung growth in adult mice. Eur Respir J 2004; 24:524-532
70. Fehrenbach H, Voswinckel R, Michl V, et al. Neoalveolarisation contributes to compensatory lung growth following pneumonectomy in mice. Eur Respir J 2008; 31:515-522
71. Paisley D, Bevan L, Choy KJ, Gross C. The pneumonectomy model of compensatory lung growth: insights into lung regeneration. Pharmacol Ther 2014; 142:196-205
72. Werner HA, Pirie GE, Nadel HR, et al. Lung volumes, mechanics, and perfusion after pulmonary resection in infancy. J Thorac Cardiovasc Surg 1993; 105:737-742
73. Laros CD, Westermann CJ. Dilatation, compensatory growth, or both after pneumonectomy during childhood and adolescence. A thirty-year follow-up study. J Thorac Cardiovasc Surg 1987; 93:570-576
74. Thurlbeck WM. Postnatal human lung growth. Thorax 1982; 37:564-571
75. Rao L, Tiller C, Coates C, et al. Lung growth in infants and toddlers assessed by multi-slice computed tomography. Acad Radiol 2010; 17:1128-1135
76. Schittny JC, Mund SI, Stampanoni M. Evidence and structural mechanism for late lung alveolarization. Am J Physiol Lung Cell Mol Physiol 2008; 294:L246-L254
77. Hyde DM, Blozis SA, Avdalovic MV, et al. Alveoli increase in number but not size from birth to adulthood in rhesus monkeys. Am J Physiol Lung Cell Mol Physiol 2007; 293:L570-L579
78. Aslam M, Baveja R, Liang OD, et al. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med 2009; 180:1122-1130
79. Pierro M, Ionescu L, Montemurro T, et al. Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia. Thorax 2013; 68:475-484. Treatment with cord-derived stem cells protects against experimental BPD in hyperoxia-exposed newborn rats
80. Van Haaften T, Byrne R, Bonnet S, et al. Airwa y delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med 2009; 1-55
81. Ionescu L, Byrne RN, van Haaften T, et al. Stem cell co nditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. Am J Physiol Lung Cell Mol Physiol 2012; 303: L967-977
82. Baker CD, Seedorf GJ, Wisniewski BL, et al. Endothelial colony-forming cell conditioned media promote angiogenesis in vitro and prevent pulmonary hypertension in experimental bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2013; 305:L73-81
83. O'R eilly M, Thebaud B. Cell-based strategies to reconstitute lung function in infants with severe bronchopulmonary dysplasia. Clin Perinatol 2012; 39:703-725
84. Petersen TH, Calle EA, Zhao L, et al. Tissue-engineered lungs for in vivo implantation. Science 2010; 329:538-541
85. Baker CD, Balasubramaniam V, Mourani PM, et al. Cord blood angiogenic progenitor cells are decreased in bronchopulmonary dysplasia. Eur Respir J 2012; 40:1516-1522
86. Thebaud B, Abman SH. Bronchopulmonary dysplasia: where have all the vessels gone Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med 2007; 175:978-985
87. Borghesi A Massa M Campanelli R et al. Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2009 180 540-546
88. Estes ML, Mund JA, Mead LE, et al. Application of polychromatic flow cytometry to identify novel subsets of circulating cells with angiogenic potential. Cytometry A 2010; 77:831-839
89. Baker CD, Abman SH. Umbilical cord stem cell therapy for bronchopulmonary dysplasia: ready for prime time Thorax 2013; 68:402-404.